New formula developed to reassure patients about low heart attack risk

November 16, 2011, Johns Hopkins University

(Medical Xpress) -- If your doctor says you have a negative stress test, or that your cholesterol or blood pressure are normal, how assured can you be that you’re not likely to have a heart attack in the next seven to 10 years? Assessing traditional risk factors, such as age, high blood pressure, cholesterol, smoking and family history can estimate a person’s risk, but the picture is not always clear-cut. Some newer tests can be offered to provide reassurance or guidance about the need for medications or further testing. 

Michael Blaha, M.D., M.P.H, from the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, has developed a simple mathematical formula to help doctors calculate their patients’ risks based on a variety of tests, such as a blood test for C-reactive protein, carotid ultrasound and coronary calcium scoring, which are not part of the usual menu of risk factors. The goal was to determine which test, if results were normal, would provide the most reassurance for patients.

The study shows that by far, a test that looks for coronary calcium is the best indicator of low risk compared with other tests. Blaha will present the results of the study, “Comparing Zero Coronary Artery Calcium with Other Negative Risk Factors for Coronary Heart Disease,” at the American Heart Association Scientific Sessions.

Blaha and his colleagues used data from the Multi-Ethnic Study of Atherosclerosis (MESA), a longitudinal study of more than 6,800 people without cardiovascular disease at enrollment who have been followed for an average of seven years. They compared heart attack rates in the study population with results of tests the individuals had been given to assess their risk. In that way, the researchers could calculate which tests predicted the lowest heart attack risk. They found that a coronary calcium score of zero, meaning no coronary calcium could be seen in heart arteries, was, by far, the most reassuring indicator.    

“None of the other tests, such as C-reactive protein, are sensitive enough to reassure patients that they have a very low risk of a heart attack over the next seven years,” says Blaha. “The findings related to coronary artery calcium are important from a public health perspective because they mean we can identify people who do not need further testing or medical interventions for the immediate future.”  

Coronary calcium scoring is a CT test that uses about the same amount of radiation as a mammogram to show evidence of calcium buildup in arteries feeding the heart. C-reactive protein is a marker of inflammation somewhere in the body that is assessed by a blood test. Carotid ultrasound looks at fatty deposits in arteries or thickening of the artery walls in the neck. 

According to Blaha’s new model, if a patient is thought to have a 10 percent risk of a heart attack, according to the widely regarded Framingham risk scale, and the patient’s calcium scoring test shows zero coronary calcium, his projected risk could be reduced to 3 percent. “That’s a meaningful change in the estimated risk that will influence patient treatment,” Blaha says. Half of the people in MESA between age 45 and 84 had zero levels of coronary calcium.

In contrast, for the same group of people whose risk of a heart attack in over the next decade was thought to be 10 percent because of traditional risk factors, a low C-reactive protein level only reduced their true risk to nine percent, according to Blaha’s model. “Therefore,” says Blaha, “finding no coronary calcium is a much more robust predictor of low risk compared with having low levels of C-reactive protein.”

Along the same lines, those with a 10 percent risk of a heart attack based on traditional , whose carotid artery test is normal, would see a drop in their risk to seven percent, based on Blaha’s model.

“This ingenious mathematical model may provide a useful tool to help physicians assess their patients’ risk,” says Roger S. Blumenthal, M.D., professor of medicine and director, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. “It may also have public health significance in terms of guiding the proper allocation of health care resources, including medications.”

Blumenthal says coronary calcium scoring to assess heart disease risk is analogous to a bone density test to assess the risk of bone fracture. “If a 60-year-old woman has a family history of osteoporosis and is thin,” he explains, “she may be presumed to be at high risk for bone fractures. A bone density scan would provide a key piece of information about her actual risk and need for medication to lower her risk of fractures.”

He adds, “We don’t prescribe medicine to prevent fractures to all postmenopausal women— only to those who have osteoporosis on the basis of a bone density scan. In the same way, coronary calcium scoring can tell us whether or not there is evidence of hardening in the walls of the heart arteries and therefore, more accurately determine a person’s risk of a or other cardiac event.”

Explore further: Study finds coronary calcium beats C-reactive protein for predicting heart attack and stroke risk

Related Stories

Study finds coronary calcium beats C-reactive protein for predicting heart attack and stroke risk

August 19, 2011
The presence of calcium in coronary arteries is a much better predictor of heart attack and stroke than C-reactive protein among people with normal levels of LDL cholesterol, according to a study of more than 2,000 people ...

Diabetics' coronary calcium levels strongly linked to heart attack risk

September 26, 2011
Notable levels of calcium buildup in coronary arteries can be strong predictors of heart attacks and strokes in people with diabetes and metabolic syndrome, according to a study led by UC Irvine's Heart Disease Prevention ...

CT angiography improves detection of heart disease in African-Americans

June 28, 2011
Researchers may have discovered one reason that African Americans are at increased risk for heart attacks and other cardiovascular events.

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.